药理学
5年影响因子:3.793
国外数据库收录:IM,3.857" />
医学全在线
医学全在线首页-医师-药师-护士-卫生资格-高级职称-考试题库-网校-考研-图谱-下载-招聘  
分类
国家级省级浙江省各省杂志
科技核心北大核心CSCDCSCD扩展
工具
期刊知识写作指导 论文投稿推荐期刊
期刊验证论文检测 录用通知往期目录
SCI
SCI指导影响因子
期刊点评基金动态
其它
经济教育计算机
建筑体育农业
北京|天津|河北|山西|湖北|江苏|安徽|山东|上海|浙江|江西|福建|湖南|宁夏|内蒙古|河南
四川|重庆|贵州|云南|辽宁|吉林|广东|广西|海南|陕西|甘肃|新疆|青海|卫生部直属|黑龙江|兵团
您现在的位置: 医学全在线 > 医学论文 > SCI期刊 > 正文:Pharmacogenomics if:3.857
    

Pharmacogenomics


Pharmacogenomics
影响因子: 3.857
I S S N: 1462-2416
出 版 社: Future Medicine Ltd
出 版 地: London
出版国家: England
刊  期: 双月刊
创刊时间: 2000
语  种: 英文
审稿周期: 偏慢,4-8周
中科院分区: 2
投稿命中率: 较易
国外数据库收录: IM
中国收录文章数: 23
5年影响因子: 3.793
研究领域: 基因组学、药理学
官方链接: http://www.futuremedicine.com/loi/pgs
投稿须知: http://www.futuremedicine.com/loi/pgs

期刊介绍:

Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. Pharmacogenomics focuses on those aspects that have the most direct relevance to the pharmaceutical industry and wider clinical community, including: The emergence of new pharmacogenomic initiatives and their impact on R&D and regulatory strategies; Emerging technologies for accessing and exploiting genomic information; Reviews of genotyping and clinical data in particular therapeutic areas; Development of novel diagnostic products and strategies. Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field.
...
关于我们 - 联系我们 -版权申明 -诚聘英才 - 网站地图 - 网络课程 - 帮助
医学全在线 版权所有© CopyRight 2006-2046, MED126.COM, All Rights Reserved
浙ICP备12017320号
百度大联盟认证绿色会员实名网站 360认证可信网站 中网验证